Mikrobiom jelitowy a zdrowie sercowo-naczyniowe: stan wiedzy

Hendrik Bartolomaeus i wsp. Precarious Symbiosis Between Host and Microbiome in Cardiovascular Health. Hypertension. 2019;73:926–935 (dostępny pełen tekst)

Animal experiments and human trials have produced growing evidence implicating the gut microbiota and its metabolites in cardiovascular disease. High-throughput sequencing technologies and metabolomics opened a new avenue to decipher the interrelationship between lifestyle, diet, pharmacotherapy, and the gut microbiome. Microbiomes from diseased and nondiseased individuals differ, exhibiting a dysbiotic, as opposed to eubiotic, state as shown for several inflammatory, cardiovascular, and metabolic disorders, including hypertension …

Hypertension, maj 2019